Technology Transfer Office | University of Colorado

CU Technologies Available for Licensing

Technology Transfer Office of University of Colorado
Browse by Category
Life Science
Physical Science
Technology Transfer Office of University of Colorado
Back to Main Page
     Key Word Search
     View Our Pipelines
     Sign up for Tech Alert
Therapeutic-New Use or Method of Treatment (12)
Tech. ID Technology Summary Available? TTO Contact
7077H Diagnosis and Treatment of Myocardial Failure using Myosin Heavy Chains Yes, download Paul Tabor
CU1267H Diagnostic And Therapeutic Potential Of Novel Leukemia-Specific MER Proteins In Leukemia And Lymphoma Yes, download Heather Callahan
CU1881H Investigation of Epigenetic Modulation in Multiple Myeloma No, contact TTO David Poticha
CU2065H Anti-Inflammatory Potential of HIF Prolyl Hydroxylases No, contact TTO Brian Bellesheim
CU2262H Timed-Release Formulations of GTS-21 and Related Arylidene-Anabaseines No, contact TTO Paul Tabor
CU2650H Nebivolol Treatment in Pediatric Heart Failure Patients No, contact TTO Doreen Molk
CU2745H A New Anti-Androgen, MDV3100, Can be Used as a Therapeutic Anti-Androgen or Anti-Estrogen Agent to Block Hormone-Dependent Growth in Breast Cancer No, contact TTO Brian Bellesheim
CU2761H COPD Prognosis, Diagnosis and Therapy: A Personalized Medicine Approach Yes, download Heather Callahan
CU2787H Use of Photosensitive Agents and LDL Receptor Ligands to Target the Aqueous Outflow System of the Eye and Decrease Intraocular Pressure No, contact TTO Heather Callahan
CU2828H Cystathionine for Treatment of Liver and Kidney Injury, Cardiovascular Protection & Chemotherapy Potentiation (COMBINED WITH CU2280H and CU2827H, UPDATE CU2828H) Yes, download Heather Callahan
CU3030B Trehalose as a treatment for vascular dysfunction, inflammation, oxidative stress and overall physical dysfunction (reduced exercise capacity and low physical activity levels) No, contact TTO Molly Markley
CU3044H Combination of Bendamustine and the HDAC Inhibitor SNDX-275 Enhances Apoptosis and DNA Damage Response in Multiple Myeloma Cells No, contact TTO David Poticha
Export to Excel      Back to Main Page